APYP (AppYea) EPS (Basic) : $-0.00 (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is AppYea EPS (Basic)?

AppYea's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was $-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.00.

AppYea's EPS (Diluted) for the three months ended in Sep. 2024 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.00.

AppYea's EPS without NRI for the three months ended in Sep. 2024 was $-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

AppYea EPS (Basic) Historical Data

The historical data trend for AppYea's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AppYea EPS (Basic) Chart

AppYea Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.40

-0.09

-0.03

-0.01

AppYea Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-	-	-	-

AppYea EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

AppYea's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.817	-	0)	/	257.223
	=	-0.01

AppYea's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.512	-	0)	/	483.924
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

AppYea (OTCPK:APYP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AppYea EPS (Basic) Related Terms

Thank you for viewing the detailed overview of AppYea's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

AppYea Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » AppYea Inc (OTCPK:APYP) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Natan Alterman Street, Gan Yavne, ISR

Website

https://www.appyea.com

AppYea Inc through its wholly-owned subsidiary SleepX, is an Israeli research and development company that has developed a product for monitoring and treating sleep apnea and snoring. It is a digital health company, focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring and fundamentally improve quality of life. Its solutions are based on its proprietary intellectual property portfolio comprised of Artificial Intelligence (AI) and sensing technologies for the tracking, analysis, and diagnosis of vital signs and other physical parameters during sleep time, offering extreme accuracy at affordable cost.

Executives

Boris Molchadsky	director, 10 percent owner, officer: Active Chairman	16 NATAN ALTERMAN ST., GAN YAVNE L3 7085118
Douglas O Mckinnon	officer: CEO CFO	2104 RIDGE PLAZA DR, CASTLE ROCK CO 80108
Keri Williams	director, 10 percent owner, officer: Secretary	916 SUN DOWN DRIVE, STEPHENVILLE TX 76401
Jackie Williams	director, 10 percent owner, officer: CEO, CFO, President	147 BEN HOGAN DRIVE, APT B, STEPHENVILLE TX 76401